The shares of the prominent chemical manufacturer gained up to 4 percent in today’s trading session after the company’s revenue surged by 103 percent YoY and turned a net profit in Q4.
With a market capitalization of Rs 10,559.49 crore, the shares of Aether Industries Ltd were trading at Rs 796.40 per share, decreasing around 3.62 percent as compared to the previous closing price of Rs 823.85 apiece.
Matter Explanation
According to the exchange filing, Aether Industries Ltd reported positive results in Q4FY25, revenue increased by 9 percent on a quarter-on-quarter basis from Rs 220 crore in Q3FY25 to Rs 240 crore in Q4FY25. Further, revenue increased by 103 percent year on year, from Rs 118 crore in Q4FY24 to Rs 240 crore in Q4FY25.
The company’s net profit increased by 16 percent on a quarter-on-quarter basis, from Rs. 43 crore in Q3FY25 to Rs. 50 crore in Q4FY25. Further, net loss turned into profits year on year from a loss of Rs 1 crore in Q4FY24 to a profit of Rs 50 crore in Q4FY25.
The company posted a strong FY24-25 performance, with revenue surging 40 percent from Rs 598 crore to Rs 839 crore. Net profit jumped 93 percent, from Rs 82 crore to Rs 158 crore, reflecting growth and improved profitability over the previous financial year.
In Q4FY25, the Pharma segment led revenue contribution at 38.33 percent, followed by Agro at 17.20 percent, Material Science at 20.77 percent, and Oil & Gas at 13.74 percent. Other segments like Coatings and High Performance Photography had smaller shares, while Sustainability & Renewables recorded 2.76 percent revenue contribution during the quarter.
Prominent investor
A prominent foreign institutional investor, Goldman Sachs, holds 15,55,029 equity shares, equivalent to 1.17 percent, in the company as of March 2025. Aether Industries Limited is focused on producing advanced intermediates and specialty chemicals involving differentiated chemistry and technology. The Company is also a provider of Contract Research and Manufacturing Services (CRAMS) and contract / exclusive manufacturing services, built upon technology, research and development (R&D), and Pilot Plant facilities.
Written by Abhishek Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
